Search results for "OUTCOME"

showing 10 items of 5148 documents

Implants in patients with oral manifestations of autoimmune or muco-cutaneous diseases – A systematic review

2018

Background To give an overview on implant survival rates in patients with oral manifestations of systemic autoimmune (oral Lichen planus (oLp), Pemphigus (Pe)), muco-cutaneous (Epidermolysis bullosa (EB)), autoimmune multisystemic rheumatic diseases (Sjögren´s syndrome (SjS), systemic Lupus erythematosus (sLE), or systemic Sclerosis (sSc)). Material and Methods Systematic literature review (PubMed/Medline, Embase) using MESH and search term combinations, published between 1980 and August 2018 in English language reporting on dental implant-prosthetic rehabilitation of patients with oLp, Pe, EB, SjS, sLE, sSc, study design, age, gender, follow-up period (≥ 12 months), implant survival rate. …

medicine.medical_specialtyDatabases FactualReviewScleroderma03 medical and health sciences0302 clinical medicinemedicineHumansLupus Erythematosus SystemicDental Restoration Failureskin and connective tissue diseasesGeneral DentistrySurvival rateDental ImplantsScleroderma SystemicLupus erythematosusintegumentary systembusiness.industryDental prosthesis030206 dentistry:CIENCIAS MÉDICAS [UNESCO]Medically compromised patients in Dentistrymedicine.diseaseDermatologystomatognathic diseasesPemphigusSjogren's SyndromeTreatment OutcomeOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASSurgeryOral lichen planusDental Prosthesis Implant-SupportedImplantEpidermolysis bullosaEpidermolysis BullosaMouth DiseasesbusinessPemphigusLichen Planus OralMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Pulmonary embolism hotline 2012. Recent and expected trials.

2012

SummaryManagement of acute pulmonary embolism (PE) has advanced considerably in the past year, and progress is expected to continue in 2013. To help determine the optimal management strategy for normotensive patients with intermediate-risk PE, the Pulmonary Embolism Thrombolysis (PEITHO) study completed enrolment of 1006 patients with evidence of right ventricular dysfunction (by echocardiography or computed tomography) plus a positive troponin test. Patients have been randomised to thrombolytic treatment with tenecteplase versus placebo, and the effects on clinical end points (death or haemodynamic collapse) assessed at 7 and 30 days. The results are expected in spring 2013; long-term foll…

medicine.medical_specialtyDeep veinmedicine.medical_treatmentTenecteplase030204 cardiovascular system & hematology03 medical and health scienceschemistry.chemical_compound0302 clinical medicineFibrinolytic AgentsEdoxabanmedicineHumans030212 general & internal medicineRivaroxabanClinical Trials as TopicEvidence-Based Medicinebusiness.industryHematologyThrombolysismedicine.diseaseThrombosisPulmonary embolismSurgerymedicine.anatomical_structureTreatment OutcomechemistryAnesthesiaApixabanbusinessPulmonary Embolismmedicine.drugForecastingHamostaseologie
researchProduct

A cross‐sectional, multi‐center study on treatment of facial acne scars with low‐energy double‐pass 1450‐nm diode laser

2020

Acne scars are the ultimate outcome of acne vulgaris, a prevalent skin disorder affecting the pilo-sebaceous unit. Laser resurfacing has been demonstrated to be an efficient therapy option for acne scars. Hence, we adopted this concept and conducted a study to evaluate the safety and efficacy of low-energy double-pass 1450-nm diode laser on acne scars. This study was conducted on 48 patients with acne scars, treated at 4-week interval with low-energy double-pass 1450-nm diode laser. Patients were evaluated clinically and with photographs, at day 0, first month and third month post the final treatment and during follow-up visit. Five treatment sessions were completed by all patients. Approxi…

medicine.medical_specialtyDermatologyDouble passlaw.inventionCicatrix030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineLow energylawAcne VulgarisHumansMedicineAcne scarsAcnebusiness.industryLaser treatmentGeneral MedicineLasermedicine.diseaseHyperpigmentationDermatologyCross-Sectional StudiesTreatment Outcome030220 oncology & carcinogenesisMulti center studyLaser TherapyLasers Semiconductormedicine.symptombusinessDermatologic Therapy
researchProduct

Review of biologics in allergic contact dermatitis

2020

The resistant and recalcitrant nature of severe allergic contact dermatitis (ACD) makes its management challenging. With advances in the understanding of the cellular and molecular pathogenesis of ACD, newer therapeutic targets are becoming apparent. In particular, the use of biologics has gained momentum, given the specificity of their action. This article aims to review the presently available data on the use of biologics in ACD. English-language-based literature available on the use of biological therapy was thoroughly probed in the following databases as on October 14, 2019: PubMed, Google Scholar, The Cochrane library, Embase, Scopus, and EBSCO. The following keywords were used: "conta…

medicine.medical_specialtyDermatologyOmalizumabEtanercept030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineUstekinumabmedicineAdalimumabHumansImmunology and Allergy030212 general & internal medicineAllergic contact dermatitisBiological Productsbusiness.industryPatch Testsmedicine.diseaseDermatologyDupilumabInfliximabTreatment OutcomeDermatitis Allergic ContactSecukinumabbusinessmedicine.drugContact Dermatitis
researchProduct

Health outcomes and costs in patients with osteoarthritis and chronic pain treated with opioids in Spain: the OPIOIDS real-world study.

2020

Objective: The objective of this study was to analyze health outcomes, resource utilization, and costs in osteoarthritis patients with chronic nociceptive pain who began treatment with an opioid in real-world practice in Spain. Methods: We designed a non-interventional, retrospective, longitudinal study with 36 months of follow-up using electronic medical records (EMRs) from primary care centers, of patients aged 18+ years who began a new treatment with an opioid drug in usual practice for chronic pain due to osteoarthritis. Health/non-health resource utilization and costs, treatment adherence, pain change, cognitive functioning, and dependence for basic activities of daily living (BADL) we…

medicine.medical_specialtyDiseases of the musculoskeletal systemOsteoarthritisHealth outcomescognitive deficit03 medical and health sciences0302 clinical medicineRheumatologymedicineOrthopedics and Sports MedicineIn patientpain030212 general & internal medicineCognitive deficitOriginal Research030203 arthritis & rheumatologybusiness.industrybasic activities of daily livingChronic painopioidshealthmedicine.diseasenon-health costshealth/non-health costsosteoarthritisNociceptionRC925-935OpioidPhysical therapymedicine.symptombusinessResource utilizationmedicine.drugTherapeutic advances in musculoskeletal disease
researchProduct

Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research

2017

Executive summary A concerted effort to tackle the global health problem posed by traumatic brain injury (TBI) is long overdue. TBI is a public health challenge of vast, but insufficiently recognised, proportions. Worldwide, more than 50 million people have a TBI each year, and it is estimated that about half the world’s population will have one or more TBIs over their lifetime. TBI is the leading cause of mortality in young adults and a major cause of death and disability across all ages in all countries, with a disproportionate burden of disability and death occurring in low-income and middle-income countries (LMICs). It has been estimated that TBI costs the global economy approximately $…

medicine.medical_specialtyEVIDENCE-BASED MEDICINETreatment outcomePoison controlOther Research Radboud Institute for Molecular Life Sciences [Radboudumc 0]EMERGENCY-DEPARTMENT VISITSReviewPLACEBO-CONTROLLED TRIALMiddle income countryHealthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18]03 medical and health sciences0302 clinical medicineIntensive careBrain Injuries TraumaticJournal Articlemedicinetraumatic barin injuryHumans030212 general & internal medicineClinical careNeurologic diseasePsychiatryDIAGNOSTIC MANAGEMENT STRATEGIESbusiness.industryRANDOMIZED CONTROLLED-TRIALACUTE SUBDURAL-HEMATOMASEVERE HEAD-INJURYROAD TRAFFIC INJURIESbrain injuryHospital care3. Good healthReconstructive and regenerative medicine Radboud Institute for Health Sciences [Radboudumc 10]Brain InjuriesHealth care costPATIENT-REPORTED OUTCOMESHuman medicineNeurology (clinical)businessHumanities030217 neurology & neurosurgeryGLASGOW COMA SCALE
researchProduct

Treatment outcomes in hepatitis C virus genotype 1a infected patients with and without baseline NS5A resistance‐associated substitutions

2020

Background&aims The presence of baseline resistance-associated substitutions (RASs) reduced sustained virologic response (SVR) rates in chronic hepatitis C virus (HCV) genotype 1a infected patients treated with Elbasvir/Grazoprevir (EBR/GZR). This study aimed to evaluate the frequency of NS5A RASs and treatment outcomes in patients for whom EBR/GZR was intended. Methods We sequenced NS5A in 832 samples from German genotype1a-infected DAA-naive patients population-based, which were collected in the European Resistance Database. Treatment outcomes and clinical parameters were evaluated in 519 of these patients retrospectively. Results Overall, 6.5% of patients harbored EBR-specific NS5A RASs …

medicine.medical_specialtyElbasvirHepatologybusiness.industryHepatitis C virusTreatment outcomemedicine.disease_causeGastroenterology03 medical and health sciences0302 clinical medicineGenotype 1bGrazoprevir030220 oncology & carcinogenesisInternal medicineHepatitis C virus genotypeMedicine030211 gastroenterology & hepatologyIn patientbusinessNS5ALiver International
researchProduct

A new technique for the treatment of nasal telangiectasia using atmospheric plasma (voltaic arc dermabrasion): Postoperative pain assessment by therm…

2020

Background Nasal telangiectasias are superficial, small vessels in the ala nasi and nasolabial crease with a varying origin. They represent an unaesthetic condition, frustrating patients who frequently request their removal. Microsclerotherapy, electrosurgery, different types of laser therapy, needle-assisted electrocoagulation, and TRASER therapy have been described for treating this condition. Aims The aim of this study is to describe a novel technique that removes nasal telengectiasias using voltaic arc dermabrasion (VAD). Patients/methods Voltaic arc dermabrasion treatment was used to remove nasal telangiectasia in 23 patients. The post-treatment condition was monitored by means of phot…

medicine.medical_specialtyElectrosurgeryErythemamedicine.medical_treatmentPostoperative painDermatologyNoseElectrocoagulationArc (geometry)030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicinemedicineHumansTelangiectasisTelangiectasiaPain PostoperativeThermal infraredbusiness.industryDermabrasionSurgeryTreatment OutcomeDermabrasion030220 oncology & carcinogenesismedicine.symptombusinessJournal of cosmetic dermatologyREFERENCES
researchProduct

A Multicenter International Randomized Controlled Manikin Study on Different Protocols of Cardiopulmonary Resuscitation for Laypeople: The MANI-CPR T…

2021

Background Compression-only cardiopulmonary resuscitation (CPR) is a suggested technique for laypeople facing out-of-hospital cardiac arrest (OHCA). However, it is difficult performing high-quality CPR until emergency medical services arrival with this technique. We aimed to verify whether incorporating intentional interruptions of different frequency and duration increases laypeople's CPR quality during an 8-minute scenario compared with compression-only CPR. Methods We performed a multicenter randomized manikin study selecting participants from 2154 consecutive laypeople who followed a basic life support/automatic external defibrillation course. People who achieved high-quality CPR in 1-m…

medicine.medical_specialtyEmergency Medical ServicesEpidemiologyDefibrillationCompression-only CPR high-quality CPR laypeople training.medicine.medical_treatmentMedicine (miscellaneous)030204 cardiovascular system & hematologyCpr trainingManikinsEducation03 medical and health sciences0302 clinical medicineSecondary outcomemedicineEmergency medical servicesHumansMulticenter Studies as TopicCardiopulmonary resuscitationRandomized Controlled Trials as Topicbusiness.industrySignificant differenceBasic life support030208 emergency & critical care medicineCardiopulmonary ResuscitationClinical trialModeling and SimulationPhysical therapybusinessOut-of-Hospital Cardiac ArrestSimulation in healthcare : journal of the Society for Simulation in Healthcare
researchProduct

Effect of β-cryptoxanthin plus phytosterols on cardiovascular risk and bone turnover markers in post-menopausal women: a randomized crossover trial.

2014

Abstract Background and aim Post-menopausal women are at higher risk of cardiovascular disease and bone demineralization. Phytosterols (PS) may be used for hypercholesterolemia in some groups and β-cryptoxanthin (β-Cx) displays a unique anabolic effect on bone. Our aim was to assess the changes in cardiovascular and bone turnover markers from the oral intake of β-Cx and PS in post-menopausal women. Methods and results A randomized, double-blind, crossover study with β-Cx (0.75 mg/day) and PS (1.5 g/day), single and combined, was performed in 38 postmenopausal women. Diet was supplemented with 1 × 250 mL milk-based fruit drink/day for 4 weeks with a wash-out period of 4-weeks in between. Ser…

medicine.medical_specialtyEndocrinology Diabetes and MetabolismCampesterolOsteoporosisHypercholesterolemiaMedicine (miscellaneous)Parathyroid hormoneAdministration OralGastroenterologyBone and BonesBone remodelingchemistry.chemical_compoundDouble-Blind MethodRisk FactorsInternal medicineStatistical significancemedicineHumansCryptoxanthinsTriglyceridesAgedNutrition and DieteticsCross-Over StudiesDose-Response Relationship Drugbusiness.industryCholesterol HDLPhytosterolsCholesterol LDLMiddle Agedmedicine.diseaseCrossover studySitosterolsHealthy VolunteersClinical trialPostmenopauseEndocrinologyCholesterolTreatment OutcomechemistrySelective estrogen receptor modulatorCardiovascular DiseasesDietary SupplementsFemaleCardiology and Cardiovascular MedicinebusinessNutrition, metabolism, and cardiovascular diseases : NMCD
researchProduct